3,4-dihydroxyphenylacetaldehyde has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 99 | 0 | 50 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HD; Haring, JH; Mattammal, MB; Raghu, G; Strong, R | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and gamma-aminobutyric acid
| Article | Year |
|---|---|
An endogenous dopaminergic neurotoxin: implication for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Culture Techniques; Dopamine; Dopamine Uptake Inhibitors; gamma-Aminobutyric Acid; L-Lactate Dehydrogenase; Mesencephalon; Neostriatum; Nerve Endings; Parkinson Disease; PC12 Cells; Radioligand Assay; Rats; Synaptosomes | 1995 |